What's in the Latest Issue?
Protecting the Castle
Pat Dorsey of Dorsey Asset Management explains how he assesses a company’s competitive moat, why he thinks business-quality-first investors have hit a rough patch, why he’s relying more on qualitative evidence in making decisions, and what he thinks the market is missing today in Veeva Systems, Tyler Technologies, Meta Platforms and Royalty Pharma.
Before the Dawn
Cambiar Investors’ Brian Barish and Rich Carney describe why investing based on mean reversion is getting harder, how "noise" in areas like healthcare and consumer products is creating opportunity, the lessons they learned from the Internet bubble, and why they believe Medtronic, Elevance Health, Constellation Brands and Expand Energy are mispriced.
Strategy: Compounders
AI is upending revered business models. Here's how one quality-first investor is responding.
Uncovering Value: Grupo GPS
Is this a proverbial baby thrown out with the bathwater because of changing political winds?
A Fresh Look: Nu Holdings
Envisioning the day when the share performance better reflects how well the business is doing.
Investment Highlights
ASML Holding, Grupo GPS, Nu Holdings, S&P Global, Constellation Brands, Elevance Health, Expand Energy, Medtronic, Meta Platforms, Royalty Pharma, Tyler Technologies, Veeva Systems
Other Companies in this Issue:
Broadcom, Amazon.com, American Express, Axon Enterprise, Booking Holdings, Danaher, EquipmentShare, Intercontinental Exchange, Mastercard, PepsiCo, Sunbelt Rentals